Bipolar versus monopolar transurethral resection of non-muscle-invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trials
- PMID: 32462303
- DOI: 10.1007/s00345-020-03271-3
Bipolar versus monopolar transurethral resection of non-muscle-invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trials
Abstract
Purpose: To compare the efficacy and safety of bipolar and monopolar transurethral resection of bladder tumors (TURBT) in non-muscle invasive bladder cancer (NMIBC) treatment.
Methods: A systematic search of all Randomized Controlled Trials (RCTs), which compared bipolar TURBT (bTURBT) and monopolar TURBT (mTURBT) in NMIBC treatment, were performed in PubMed, Web of Science, Cochrane Library and Embase up to February 1, 2019. We evaluated their efficacy by operative time, hospitalization time, catheterization time, and recurrence rate. While obturator jerk, bladder perforation, thermal damage, and overall complications were used to evaluate their safety.
Results: A total of 13 RCTs, involving 2379 patients, were included. There were no statistically significant differences in efficacy between bTURBT and mTURBT in NMIBC treatment, such as operative time (p = 0.12), hospitalization time (p = 0.13), catheterization time (p = 0.50), and recurrence rate (p = 0.88). Compared to the safety in mTURBT in NMIBC treatment, no significant advantages were observed in that in bTURBT as well, such as obturator jerk (p = 0.12), bladder perforation (p = 0.11), thermal damage (p = 0.24), and overall complications (p = 0.65).
Conclusions: Our analysis demonstrated that bTURBT has no significant advantages in efficacy and safety in NMIBC treatment compared to that in mTURBT. Thus, bTURBT could not completely replace mTURBT as a safer and more effective NMIBC treatment.
Keywords: Bipolar; Meta-analysis; Monopolar; Non-muscle invasive bladder cancer; Transurethral resection.
Comment in
-
Comment on "Bipolar versus monopolar transurethral resection of non-muscle-invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trials".World J Urol. 2021 Sep;39(9):3691-3692. doi: 10.1007/s00345-020-03292-y. Epub 2020 Jun 10. World J Urol. 2021. PMID: 32524256 No abstract available.
References
-
- Gramann T, Schwab C, Zumstein V et al (2018) Transurethral resection of bladder cancer on the lateral bladder wall without obturator nerve block: extent of adductor spasms using the monopolar versus bipolar technique-a prospective randomized study. World J Urol 36(7):1085–1091 - DOI
-
- Witjes JA, Bruins HM, Cathomas R et al (2020) European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol. https://doi.org/10.1016/j.eururo.2020.03.055
-
- Monteiro LL, Witjes JA, Agarwal PK et al (2019) ICUD-SIU international consultation on bladder cancer 2017: management of non-muscle invasive bladder cancer. World J Urol 37(1):51–60 - DOI
-
- Zhang J, Wang L, Mao S et al (2018) Transurethral en bloc resection with bipolar button electrode for non-muscle invasive bladder cancer. Int Urol Nephrol 50(4):619–623 - DOI
-
- Gunlusoy B, Bolat D, Degirmenci T (2019) Re: "Monopolar vs. bipolar transurethral resection for nonmuscle invasive bladder carcinoma: a post hoc analysis from a randomized controlled trial". Urol Oncol 37(3):177–178
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical